Generics 25

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Pramipexole manufacturers

25 products found

Filters

25 products found

pramipexole

Tablets, prolonged release (PR) 0.26 mg, 0.52 mg, 1.05 mg , 1.57 mg, 2.10 mg, 2.62 mg , 3.15 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #419

Manufacturer usually replies in 3 days

pramipexole

Tablets, immediate release (IR) 0.088 mg, 0.18 mg, 0.35 mg, 0.7 mg, 1.1 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Austria , Belgium , Bulgaria , Croatia , Cyprus , Czech Republic , Denmark , Estonia , Finland , France , Germany , Greece , Italy , Latvia , Liechtenstein , Lithuania , Luxembourg , Malta , Netherlands , Norway , Poland , Portugal , Spain , Sweden , United Kingdom , Vietnam
Available for
Licensing with supply, Distribution only
Manufacturer #573
A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, Africa, and Asia for 30+ years. Key production lines are Rx and nutraceuticals. Main therapeutic areas include CNS and respiratory. Main dosage forms include sterile forms and oral solid. The company's production lines are EU GMP-compliant. The company owns 10+ branches in Europe.

Manufacturer usually replies in 7 days

pramipexole

Tablets 1.25mg, 0.25mg, 1mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #425
A pharmaceutical manufacturer based in Europe that has been active in Europe for 20+ years. Main therapeutic areas include CNS, urology, and cardiovascular system. The key production line is Rx. The main dosage form is solid form.

Manufacturer usually replies in 8 days

pramipexole

Tablets, modified release (MR) 0.26, 0.52, 1.05, 1.57, 2.1, 2.62, 3.15mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #12186
The activity of the company is based on the development of highly competitive processes for the manufacture of active ingredients with high added value that meet the strictest quality specifications. They manufacture under strict compliance with the environmental and occupational safety regulations in force in Europe. They focus on the pharmaceutical, hospital, diagnostic, fine chemical, and food fields. Its products are marketed in more than 70 countries.

Manufacturer usually replies in 7 days

pramipexole

Tablets 0.25, 1mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #12186
The activity of the company is based on the development of highly competitive processes for the manufacture of active ingredients with high added value that meet the strictest quality specifications. They manufacture under strict compliance with the environmental and occupational safety regulations in force in Europe. They focus on the pharmaceutical, hospital, diagnostic, fine chemical, and food fields. Its products are marketed in more than 70 countries.

Manufacturer usually replies in 7 days

pramipexole

Tablets 0.25 mg, 0.5 mg, 1 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15070

A pharmaceutical manufacturer based in the EU that is selling its products in EU, CIS, and Asia. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 7 days

pramipexole

Tablets 0.088 mg, 0.18 mg, 0.35 mg, 0.7 mg, 1.1 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, FDA
Manufacturer #17457
In the past fifty years, the company has reached significant milestones—a result of enviable performance, strict adherence to the highest ethical and operational standards, and full compliance with global regulatory authorities. During this journey, they have emerged as one of the leading in-house development partners based in Europe, specializing in the development, registration, manufacturing, and life-cycle management of highly complex pharmaceutical technologies and generic formulations.

Manufacturer usually replies in 23 days

pramipexole

Tablets 0.088 mg, 0.18 mg, 0.35 mg, 0.7 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Czech Republic , Germany , Netherlands , Poland , Romania , Slovakia , Spain , United Kingdom
Comments
DCP approved
Manufacturer #6978

Manufacturer usually replies in 3 days

pramipexole

Tablets 0.25 mg, 1 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
Ukraine
GMP approvals
EU GMP
MAs for sale
Ukraine
Manufacturer #16118
The pharmaceutical plant follows the European standard throughout the plant. The core belief of the plant is to make sure that the customer receives the best pharmaceutical benefits as well as the intended patient care services.

Manufacturer usually replies in 7 days

pramipexole

Tablets 0.125 mg, 0.25 mg, 0.5 mg, 0,75 mg, 1 mg, 1 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Unavailable markets
South Africa
Manufacturer #638

Manufacturer usually replies in 8 days

pramipexole

Tablets 0.5 mg, 0.25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20162

Manufacturer usually replies in 3 days

pramipexole

Tablets 0.125 mg, 0.25 mg, 0.50 mg, 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18285

Manufacturer usually replies in 3 days

pramipexole

Tablets 0.18 mg, 0.35 mg, 0.75 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
FDA
Manufacturer #20781
The vision of the company is to develop and promote local expertise in the pharmaceutical industry. With the mission of quality medicines, health, and well-being of people and the environment. They manufacture and market high-quality branded generics in more than 40 countries across the globe.

Manufacturer usually replies in 9 days

pramipexole

Tablets 0.125 mg, 0.25 mg, 0.5 mg, 1 mg, 1.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19372

Manufacturer usually replies in 7 days

pramipexole

Tablets, extended release (ER) 0.375 mg, 0.75 mg, 1.5 mg, 2.25 mg, 3 mg, 3.75 mg, 4.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #16875
In the 1920s, it was one of 150+ firms founded in southeast Europe. In its early years, it manufactured and marketed pharmaceutical items under the licensing of global corporations. In the early 1980s, the company began importing completed pharmaceutical items and manufacturing and marketing identical products, establishing itself as a major participant in the local pharmaceutical industry. For more than 50 years, it has provided the pharmaceutical business with more than 210 different pharmaceutical goods, over 70 brands, and the manufacture of high-quality drugs, and continues to work with international companies.

Manufacturer usually replies in 6 days

pramipexole

Tablets 0.25mg, 1mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Available for
Distribution only
Manufacturer #16240
It is a laboratory that produces several product lines, such as allergy, cardiology, clinic, dermatology, gastroenterology, geriatrics, neurology, pediatrics, psychiatry, and urology, among others.

Manufacturer usually replies in 6 days

pramipexole

Tablets, prolonged release (PR) 0.375mg, 0.75,mg, 1.5mg, 3mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16189
A pharmaceutical leader that deals with the development, manufacturing, and commercializing of pharmaceutical specialties, medicines as well as drugs to improve patient health and condition. The goal is to offer the utmost medical attention that goes with time and keeps the service delivery optimum.

Manufacturer usually replies in 7 days

pramipexole

Tablets 0.25mg, 0.5mg, 1mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16189
A pharmaceutical leader that deals with the development, manufacturing, and commercializing of pharmaceutical specialties, medicines as well as drugs to improve patient health and condition. The goal is to offer the utmost medical attention that goes with time and keeps the service delivery optimum.

Manufacturer usually replies in 7 days

pramipexole

Tablets 0.25mg, 1mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16113
An innovative pharmaceutical company that is one of the leading producers of anti-inflammatory and anti-rheumatic drugs. With an innovative strategy for growth, the company is focused on combining scientific knowledge with a technological breakthroughs.

Manufacturer usually replies in 5 days

pramipexole

Tablets 0.38 mg, 0.75 mg, 1.50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #463

Manufacturer usually replies in 11 days

Want to view all 25 products? Create your free account today!

Pramipexole Manufacturers

Pramipexole is a medication used to treat Parkinson’s disease, tardive dyskinesia, and restless leg syndrome. Suppliers of pramipexole medications market it in the form of 0,08 – 3,15mg standard-release as well as prolonged-release oral tablets. The drug was first approved for medical use by the FDA in 1997, with the earliest manufacturer and supplier being Boehringer Ingelheim. Currently, pramipexole is approved in over 80 countries worldwide, such as China, Australia, Brazil, Japan, and the EU, and is a widely prescribed medication (with over 2 million prescriptions are registered yearly in the U.S. alone). Starting in 2006, other pramipexole manufacturers and suppliers have joined the market for the drug. Currently, they include major pharmaceutical companies Hexal, STADA, Sanofi-Aventis, Teva, Sandoz, and KRKA. Pramipexole suppliers and distributors market both generic and trade name formulations of the drug. The symptomatic management of Parkinson's disease is advised for the use of this medication. You can use this medication alone or in combination with levodopa. Additionally, it is suggested for the symptomatic management of mild to moderate primary restless legs syndrome.

How Does Pramipexole Work?

At this moment, it is unclear exactly how pramipexole works to treat Parkinson's disease. The striatum of the mind, a region that gets a wide range of neurological information and is in charge of a wide variety of processes, is assumed to be implicated because of pramipexole's capacity to stimulate dopamine receptors there. Studies demonstrate that pramipexole affects the speed of striatal neuronal transmission once dopamine receptors are activated. Pramipexole is a non-ergot dopaminergic agonist that binds selectively to dopamine D2 receptors and has significant action at the D2 subfamily of dopaminergic in vitro, preferring the dopamine D3 receptor subtype over other subtypes. This binding specificity's clinical relevance is unknown.

Wholesale Price of Pramipexole

The retail prices of pramipexole vary, depending on the concentration of the active ingredient, whether it is a generic or trade name formulation, as well as manufacturer and supplier pricing. For example, while 0.088 pramipexole tablets cost around 2,00 EUR to 4,00 EUR, whereas prolonged-release tablets can cost from 45,00 EUR to 90,00 EUR. Also, the costs of Pramipexole vary depending on manufacturer and supplier pricing, whether it is a generic or trade name formulation, concentration of the active ingredient in the formulation. It is available or sale at every medical store. Pramipexole suppliers, on the whole, are in favor of patient aid initiatives. Pramipexole is available for sale from various Pramipexole vendors at multiple costs.

From Where to Get Pramipexole?

Making use of Pipelinepharma's worldwide B2B online marketplace for medications and other pharmaceuticals is the ideal approach to locate and acquire access to Pramipexole manufacturers and suppliers. Finding reliable suppliers and manufacturers of particular medications like Pramipexole can typically be a time-consuming challenge, but with Pipelinepharma's straightforward search engine and network of tested partners, the entire process becomes much simpler. Utilizing our built-in search engine, all you have to do to begin going is start looking for potential Pramipexole suppliers or manufacturers. You may also use filters to narrow down your search results and look for Pramipexole from particular nations.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Pramipexole offerings can be narrowed down with filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Pramipexole suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Pramipexole. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, and countries in which Pramipexole is already registered. Manufacturers also have special delivery terms.

Establishing Commercial Ties

Suppose you are a pharmaceutical licensing company or a distributor. In that case, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Pramipexole suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Pramipexole manufacturers for the quality of the pharmaceutical products' dossiers and protect against the risk of possible malpractices.